Long-range associations between enhancers and their target gene promoters have been shown 25 to play critical roles in executing genome function. Recent variations of chromosome capture 26 technology have revealed a conprehensive view of intra-and inter-chromosomal contacts 27 between specific genomic sites. The locus control region of the β-globin genes (β-LCR) is a 28 super-enhancer that is capable of activating all of the β-like globin genes within the locus in cis 29 through physical interaction by forming DNA loops. CTCF helps to mediate loop formation 30 between LCR-HS5 and 3'HS1 in the human β-globin locus, in this way thought to contribute to 31 the formation of a "chromatin hub". The β-globin locus is also in close physical proximity to 32 other erythrocyte-specific genes located long distances away on the same chromosome. In 33 this case, erythrocyte-specific genes gather together at a shared "transcription factory" for 34 co-transcription. Theoretically, enhancers could also activate target gene promoters on 35 different chromosomes in trans, a phenomenon originally described as transvection in 36 Drosophilla. Although close physical proximity has been reported for the β-LCR and the 37 β-like globin genes when integrated at the mouse homologous loci in trans, their structural and 38 functional interactions were found to be rare, possibly because a lack of suitable regulatory 3 39 elements that might facilitate trans interactions. Therefore, we re-evaluated presumptive 40 transvection-like enhancer-promoter communication by introducing CTCF binding sites and 41 erythrocyte-specific transcription units into both LCR-enhancer and β-promoter alleles, each 42 inserted into the mouse ROSA26 locus on separate chromosomes. Following cross-mating of 43 mice to place the two mutant loci at the identical chromosomal position and into active 44 chromation in trans, their transcriptional output was evaluated. The results demonstrate that 45 there was no significant functional association between the LCR and the β-globin gene in trans 46 even in this idealized experimental context.
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In the absence of a cis-linked LCR, the human -globin gene locus becomes 148 heterochromatinized (e.g. in the Hispanic thalassemia patient; [28, 29] ) and the expression of all 149 the -like globin genes is reduced in transgenic mice [30, 31] . Therefore, a -globin transgene 150 without an LCR enhancer in cis on the promoter allele is expected to be heterochromatinized 151 and to not be efficiently activated by the LCR on the enhancer allele in trans. We therefore 11 152 chose the mouse ROSA26 locus (on chromosome 6) for testing the transvection phenomenon, 
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To test for possible involvement, if any, of co-transcription of the -globin genes in 155 the enhancer and promoter alleles for transvection analysis, an -marked -globin [-globin] 156 gene sequence was surrounded by loxP sites (floxed) in the enhancer allele so that it could be 157 removed by conditional in vivo cre-loxP-mediated homologous recombination ( Fig. 1B) . To 158 test for involvement of allelic proximity mediated by CTCF factors in the transvection 159 experiment, the 3'HS1 sequence in the promoter allele was also floxed (Fig. 1C ). Following 160 homologous recombination with these targeting vectors in R1-ES cells, genomic DNA was 161 prepared and correct recombination events were confirmed by Southern blot analyses using 162 several combinations of restriction enzymes and specific probes ( Fig. 1D and 1E ).
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In vivo Cre-loxP recombination to derive daughter sublines 165 Following establishment of germ line modified mouse lines from the mutant ES cells by 166 co-culture aggregation, the one carrying the enhancer knock-in allele (LCR+β(ε)+Neo r ; Fig. 2A,   167 top) was mated with cre-expressing TgM to remove either the "Neo r " or "Neo r + -globin 12 168 gene" sequences, thereby generating either "LCR+" or "LCR" alleles, respectively (Fig.
169
2A). Similarly, "β(γ)+3'HS1" and "β(γ)" alleles were derived from lines carrying the 170 promoter knock-in allele (β(γ)+'HS1+Neo r ) by removing "Neo r " or "Neo r +3'HS1" 
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The expression level of the -globin gene linked to the LCR in cis was 16-fold 185 higher than that of the (-globin gene in isolation (Fig. 3A ). This magnitude seemed much 186 less significant than when LCR is deleted from the whole locus in endogenous [29] the GAPDH gene expression, were determined by qRT-PCR. The mouse -globin gene was 201 preferentially expressed only in the spleen, as expected ( Fig. 3B, left) . In contrast, while 202 ()-globin+3'HS1 was highly expressed in the spleen, its low level expression was also 203 observed in the liver and kidney. Since -globin gene expression was barely detected in 204 these non-hematopoietic tissues (in adults), we concluded that contamination of erythroid cells 205 in these tissues was negligible. Therefore, low level -globin+3'HS1 gene expression in 206 the liver and kidney (and probably in the spleen) was under the control of the Rosa26 promoter.
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In other words, it appears that at least 90% of -globin+3'HS1 gene transcription in the 208 spleen initiates from the -globin gene promoter.
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Confirmation of CTCF binding to the LCR-HS5 and 3'HS1 regions 211
To test for CTCF binding to well-established CTCF binding sites in LCR-HS5 and 3'HS1 of 212 the human β-globin locus in mutant animals, ChIP analyses were conducted using chromatin 213 prepared from anemic spleen (erythroid) cells ( Fig. 3C ). PCR primers for H19 ICR and 
232
Human γ-globin gene expression normalized to that of the mouse -globin gene 233 in the two groups (with or without the LCR in trans) did not differ significantly, providing no 234 evidence for trans-activation ( Fig. 4C and Supple. Fig. 1A ). Even when compared within 235 single litters, no significant difference was observed between two groups (data not shown). 
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Our observations reported here are consistent with their results (LCR x β(γ) in Fig. 4C ).
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Because enhancer-promoter looping in the β-globin gene locus is dependent on 
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Despite their significant expression in erythroid cells (Fig. 3A & B) , however, we did not 366 observe increased reporter gene expression when compared to that in the absence of a paired 367 enhancer allele in trans (Fig. 4E & F) . 
